| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 123.791 | 219.396 | 206.581 | 237.608 |
| Total Income - EUR | - | - | - | - | - | - | 123.792 | 221.823 | 206.588 | 237.725 |
| Total Expenses - EUR | - | - | - | - | - | - | 39.868 | 73.275 | 104.592 | 102.027 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 83.924 | 148.548 | 101.996 | 135.698 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 82.711 | 146.374 | 99.971 | 129.422 |
| Employees | - | - | - | - | - | - | 3 | 4 | 5 | 5 |
Check the financial reports for the company - Medor Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 3.059 | 5.999 | 4.105 | 5.585 |
| Current Assets | - | - | - | - | - | - | 85.139 | 145.135 | 101.996 | 229.940 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 8.526 | 114.932 | 18.909 | 1.250 |
| Cash | - | - | - | - | - | - | 76.613 | 30.203 | 83.087 | 228.690 |
| Shareholders Funds | - | - | - | - | - | - | 82.752 | 146.415 | 100.012 | 228.875 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 5.446 | 4.719 | 6.088 | 6.650 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medor Medical S.r.l.